JPMorgan Chase & Co’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36 | Hold |
71
| – | – | ﹤0.01% | 6029 |
|
2025
Q1 | $89 | Hold |
71
| – | – | ﹤0.01% | 6015 |
|
2024
Q4 | $97 | Hold |
71
| – | – | ﹤0.01% | 5957 |
|
2024
Q3 | $153 | Hold |
71
| – | – | ﹤0.01% | 5869 |
|
2024
Q2 | $270 | Sell |
71
-12,615
| -99% | -$48K | ﹤0.01% | 5721 |
|
2024
Q1 | $39.5K | Buy |
12,686
+8,988
| +243% | +$28K | ﹤0.01% | 5045 |
|
2023
Q4 | $12.3K | Sell |
3,698
-741
| -17% | -$2.46K | ﹤0.01% | 5340 |
|
2023
Q3 | $9.66K | Sell |
4,439
-2,086
| -32% | -$4.54K | ﹤0.01% | 5328 |
|
2023
Q2 | $26.9K | Buy |
6,525
+5,082
| +352% | +$20.9K | ﹤0.01% | 4983 |
|
2023
Q1 | $7K | Buy |
1,443
+654
| +83% | +$3.17K | ﹤0.01% | 5337 |
|
2022
Q4 | $5K | Sell |
789
-608
| -44% | -$3.85K | ﹤0.01% | 5228 |
|
2022
Q3 | $13K | Buy |
1,397
+209
| +18% | +$1.95K | ﹤0.01% | 5026 |
|
2022
Q2 | $12K | Sell |
1,188
-1,141
| -49% | -$11.5K | ﹤0.01% | 5152 |
|
2022
Q1 | $31K | Sell |
2,329
-1,857
| -44% | -$24.7K | ﹤0.01% | 5163 |
|
2021
Q4 | $68K | Buy |
+4,186
| New | +$68K | ﹤0.01% | 4969 |
|